Letter to the Editor: Group B Streptococcal Bacteremia; Experience from South India

Microb Drug Resist. 2022 Jul;28(7):819-820. doi: 10.1089/mdr.2022.0058. Epub 2022 Jun 3.

Authors

Rajalakshmi Arjun¹, Muraleedharan Jalajadevi Varsha², Vettakkara Kandy Muhammed Niyas¹, Febeena Hussain¹, Sandeep Surendran¹

Affiliations

¹ Department of Infectious Diseases, KIMSHEALTH, Thiruvananthapuram, India.
² Department of Internal Medicine, KIMSHEALTH, Thiruvananthapuram, India.

PMID: 35666205
DOI: 10.1089/mdr.2022.0058

No abstract available

Publication types

Comment

MeSH terms

Anti-Bacterial Agents / pharmacology
Bacteremia* / drug therapy
Humans
India
Streptococcal Infections* / drug therapy
Streptococcus agalactiae

Substances

Anti-Bacterial Agents